InvestorsHub Logo
Followers 13
Posts 1538
Boards Moderated 0
Alias Born 08/06/2013

Re: Technicalogist post# 29117

Tuesday, 10/17/2017 1:18:39 PM

Tuesday, October 17, 2017 1:18:39 PM

Post# of 77488
Revenue growth has deaccelerated while with an ambitious “free CBD gel campaign”, therefore something else is needed while the industry is growing at 55%. Salary line is growing disproportionately to actual revenue while shares issued has grown well over 550% in a year.
Perhaps Pet Meds can help us attain management’s stated forecast for the year. The forecast was made to be directly in line with the industry’s projection. Our Q to Q growth was LESS than 10%., 3Q 2017 versus 2Q 2017. We’ll need to do 2x last Q to now attain what was deemed a reasonable forecast.....perhaps we will.
Dilution is our greatest area of growth followed by salary growth! These are facts. I don’t know the upside for CryptoBuy but WE can see resources have been added recently to do something, RIGHT? Debt reduction is NOT a priority..
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent UBQU News